Combined nasal adaptor and cap
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
FIG. 1 is a front and left side perspective view of a combined nasal adapter and cap showing our new design;
FIG. 2 is a front elevational view thereof, the undisclosed rear view being a mirror image;
FIG. 3 is a side elevational view thereof, the undisclosed opposite side being a mirror image;
FIG. 4 is a cross section taken on line 4--4 of FIG. 5 showing the cap alone for clarity of illustration;
FIG. 5 is a bottom plan view of FIG. 4;
FIG. 6 is a top plan view of FIG. 1;
FIG. 7 is a bottom plan view of FIG. 1;
FIG. 8 is an exploded front elevational view of FIG. 1;
FIG. 9 is a side elevational view of the nasal adapter shown without the cap for clarity of illustration, the undisclosed opposite side being a mirror image;
FIG. 10 is a top plan view of FIG. 9; and,
FIG. 11 is an exploded front elevational view of FIG. 9, shown for clarity of illustration;
FIG. 12 is a right side elevational view of the bottle with nasal adaptor removed, the left side elevational view being identical thereto;
FIG. 13 is a top plan view thereof;
FIG. 14 is a bottom plan view of the nasal adaptor shown in FIG. 11;
FIG. 15 is a front perspective view of the bottle showin in FIG. 12 with valve removed; and,
FIG. 16 is a top plan view thereof.
Type: Grant
Filed: Sep 28, 1990
Date of Patent: Oct 12, 1993
Assignee: Glaxo Group Limited (London)
Inventors: Paul K. Rand (Herts), Philip M. Regan (Herts)
Primary Examiner: Bernard Ansher
Assistant Examiner: Mitchell I. Siegel
Law Firm: Darby & Darby
Application Number: 7/589,670